Factors affecting long term survival following resection for lung cancer.
Open Access
- 1 December 1996
- Vol. 51 (12) , 1266-1269
- https://doi.org/10.1136/thx.51.12.1266
Abstract
BACKGROUND: Survival following pulmonary resection for primary lung cancer is considered to be principally dependent on the clinical stage of the disease. A study was undertaken to verify this and to identify other contributing factors. METHODS: The case records of all patients who underwent surgery for lung cancer over a two year period between January 1987 and December 1988 were reviewed retrospectively. RESULTS: One hundred and forty-seven lobectomies and 60 pneumonectomies were performed with 2.8% and 5.3% operative mortality, respectively. Squamous carcinoma was the commonest pathology (60%) followed by adenocarcinoma (30%). The overall five year survival was 45.5% (95% CI 44.1% to 57.9%). There were 123 patients with stage I disease, 40 with stage II, and 37 in stage IIIa with five year survival of 59.4% (95% CI 50.8% to 68%), 30% (95% CI 15.9% to 44.1%), and 16.2% (95% CI 3.5% to 31%), respectively. There were no differences in survival with respect to sex, extent of resection, or cell type. In patients with stage II disease the five year survival of those with T1 lesions (50%, 95% CI 37.3% to 62.9%) was better than those with T2 (28.1%, 95% CI 16.9% to 39.3%). Of eight patients over the age of 70 with stage IIIa disease none survived more than 24 months. CONCLUSIONS: Stage at operation is the most accurate predictor of long term survival in early lung cancer and surgery remains an effective treatment, particularly in stage I and II disease. Further study is needed to assess the prognostic value of subdividing stage II disease into T1 and T2 lesions. Major resection for locally advanced disease in older patients may be relatively ineffective.Keywords
This publication has 22 references indexed in Scilit:
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Prognosis of unsuspected but completely resectable N2 non-small cell lung cancerThe Annals of Thoracic Surgery, 1993
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patientsThe Annals of Thoracic Surgery, 1993
- Prognostic significance of computed tomography in resected N2 lung cancerThe Annals of Thoracic Surgery, 1992
- Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lungThe Annals of Thoracic Surgery, 1992
- Hospital mortality and long-term survival after pulmonary resection in the elderlyThe Annals of Thoracic Surgery, 1991
- Aggressive surgical intervention in N2 non-small cell cancer of the lungThe Annals of Thoracic Surgery, 1991
- Role of postoperative radiation therapy in stage IIIa non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- The Importance of Surgery to Non-Small Cell Carcinoma of Lung with Mediastinal Lymph Node MetastasisThe Annals of Thoracic Surgery, 1988